Intermediate and posterior uveitis cause loss of vision if not properly treated. Treatment options with various delivery methods, and ranging from local to systemic, are explored in this review.

In this review, the author summarizes current articles on the assessment of therapeutic application of biologics for refractory uveitis including other autoimmune diseases.

Noninfectious uveitis, immunosuppressive drug therapy can significantly increase the risk of endophthalmitis after cataract surgery.